IFNAR2 and infection: Blocking TNF has previously been shown to be effective in limiting vascular leakage at late time points of infection in immunocompromised mice lacking Type I and II Interferon receptors (IFN-α,β,γ-R−/−, or AG129), which is a mouse model of DENV viremia (Zellweger et al., 2010).